(ARRY) Array Technologies - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US04271T1007
Solar Tracker, Dual-Row, Control Software
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 80.7% |
| Value at Risk 5%th | 119% |
| Relative Tail Risk | -10.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 28.94 |
| CAGR/Max DD | -0.32 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.644 |
| Beta | 1.192 |
| Beta Downside | 1.835 |
| Drawdowns 3y | |
|---|---|
| Max DD | 84.88% |
| Mean DD | 49.90% |
| Median DD | 57.14% |
Description: ARRY Array Technologies November 17, 2025
Array Technologies Inc. (NASDAQ: ARRY) designs, manufactures, and sells solar-tracking hardware and software across the United States, Spain, Brazil, Australia, and other international markets. The business is split into two operating segments-Array Legacy Operations, which focuses on the single-axis DuraTrack HZ v3 system, and STI Operations, which sells the dual-row Array STI H250, the OmniTrack, SkyLink photovoltaic-powered controller, and the SmarTrack software suite. Founded in 1987 and headquartered in Albuquerque, NM, the company is classified under the GICS sub-industry “Electrical Components & Equipment.”
Key recent metrics (as of Q3 2024) include a 14 % year-over-year increase in total revenue to $332 million, driven largely by a 22 % rise in shipments of dual-row trackers in the U.S. utility-scale segment, and a backlog of roughly $1.1 billion representing projects slated through 2026. The solar-tracker market is expanding at a compound annual growth rate of about 10 % globally, supported by declining PV module costs, rising corporate renewable-energy procurement, and continued policy incentives such as the U.S. Inflation Reduction Act, which subsidizes tracker-enabled projects.
For a deeper quantitative assessment, you may find ValueRay’s detailed valuation model useful.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-33.4m TTM) > 0 and > 6% of Revenue (6% = 80.0m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -6.00pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 30.60% (prev 53.70%; Δ -23.09pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 115.7m > Net Income -33.4m (YES >=105%, WARN >=100%) |
| Net Debt (459.5m) to EBITDA (48.9m) ratio: 9.40 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.89 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (154.1m) change vs 12m ago 1.43% (target <= -2.0% for YES) |
| Gross Margin 26.29% (prev 30.91%; Δ -4.62pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 84.01% (prev 62.84%; Δ 21.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.14 (EBITDA TTM 48.9m / Interest Expense TTM 30.9m) >= 6 (WARN >= 3) |
Altman Z'' 0.87
| (A) 0.25 = (Total Current Assets 866.5m - Total Current Liabilities 458.5m) / Total Assets 1.61b |
| (B) -0.17 = Retained Earnings (Balance) -277.1m / Total Assets 1.61b |
| (C) 0.00 = EBIT TTM 4.41m / Avg Total Assets 1.59b |
| (D) -0.24 = Book Value of Equity -284.8m / Total Liabilities 1.21b |
| Total Rating: 0.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 42.68
| 1. Piotroski 3.50pt |
| 2. FCF Yield 5.24% |
| 3. FCF Margin 6.62% |
| 4. Debt/Equity 1.68 |
| 5. Debt/Ebitda 9.40 |
| 6. ROIC - WACC (= -6.32)% |
| 7. RoE -9.66% |
| 8. Rev. Trend -15.78% |
| 9. EPS Trend 37.47% |
What is the price of ARRY shares?
As of December 14, 2025, the stock is trading at USD 8.52 with a total of 9,157,554 shares traded.
Over the past week, the price has changed by +7.58%, over one month by +1.31%, over three months by +11.08% and over the past year by +54.63%.
Over the past week, the price has changed by +7.58%, over one month by +1.31%, over three months by +11.08% and over the past year by +54.63%.
Is ARRY a buy, sell or hold?
Array Technologies has received a consensus analysts rating of 3.96.
Therefore, it is recommended to buy ARRY.
- Strong Buy: 10
- Buy: 3
- Hold: 11
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ARRY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.9 | 28.3% |
| Analysts Target Price | 10.9 | 28.3% |
| ValueRay Target Price | 7.9 | -7.5% |
ARRY Fundamental Data Overview December 10, 2025
Market Cap USD = 1.22b (1.22b USD * 1.0 USD.USD)
P/E Forward = 9.4162
P/S = 0.9176
P/B = 5.0259
P/EG = 0.6728
Beta = 1.684
Revenue TTM = 1.33b USD
EBIT TTM = 4.41m USD
EBITDA TTM = 48.9m USD
Long Term Debt = 658.4m USD (from longTermDebt, last quarter)
Short Term Debt = 22.6m USD (from shortTermDebt, last quarter)
Debt = 681.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 459.5m USD (from netDebt column, last quarter)
Enterprise Value = 1.68b USD (1.22b + Debt 681.0m - CCE 221.5m)
Interest Coverage Ratio = 0.14 (Ebit TTM 4.41m / Interest Expense TTM 30.9m)
FCF Yield = 5.24% (FCF TTM 88.3m / Enterprise Value 1.68b)
FCF Margin = 6.62% (FCF TTM 88.3m / Revenue TTM 1.33b)
Net Margin = -2.50% (Net Income TTM -33.4m / Revenue TTM 1.33b)
Gross Margin = 26.29% ((Revenue TTM 1.33b - Cost of Revenue TTM 982.7m) / Revenue TTM)
Gross Margin QoQ = 25.09% (prev 26.81%)
Tobins Q-Ratio = 1.04 (Enterprise Value 1.68b / Total Assets 1.61b)
Interest Expense / Debt = 0.74% (Interest Expense 5.05m / Debt 681.0m)
Taxrate = 22.88% (9.94m / 43.4m)
NOPAT = 3.40m (EBIT 4.41m * (1 - 22.88%))
Current Ratio = 1.89 (Total Current Assets 866.5m / Total Current Liabilities 458.5m)
Debt / Equity = 1.68 (Debt 681.0m / totalStockholderEquity, last quarter 404.6m)
Debt / EBITDA = 9.40 (Net Debt 459.5m / EBITDA 48.9m)
Debt / FCF = 5.21 (Net Debt 459.5m / FCF TTM 88.3m)
Total Stockholder Equity = 345.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.07% (Net Income -33.4m / Total Assets 1.61b)
RoE = -9.66% (Net Income TTM -33.4m / Total Stockholder Equity 345.6m)
RoCE = 0.44% (EBIT 4.41m / Capital Employed (Equity 345.6m + L.T.Debt 658.4m))
RoIC = 0.57% (NOPAT 3.40m / Invested Capital 599.4m)
WACC = 6.89% (E(1.22b)/V(1.90b) * Re(10.41%) + D(681.0m)/V(1.90b) * Rd(0.74%) * (1-Tc(0.23)))
Discount Rate = 10.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.65%
[DCF Debug] Terminal Value 60.59% ; FCFE base≈124.7m ; Y1≈81.9m ; Y5≈37.4m
Fair Price DCF = 3.43 (DCF Value 523.6m / Shares Outstanding 152.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 37.47 | EPS CAGR: 126.8% | SUE: 1.81 | # QB: 1
Revenue Correlation: -15.78 | Revenue CAGR: 16.79% | SUE: 2.80 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=-0.020 | Revisions Net=-3 | Analysts=14
EPS next Year (2026-12-31): EPS=0.89 | Chg30d=-0.029 | Revisions Net=-2 | Growth EPS=+32.1% | Growth Revenue=+14.1%
P/E Forward = 9.4162
P/S = 0.9176
P/B = 5.0259
P/EG = 0.6728
Beta = 1.684
Revenue TTM = 1.33b USD
EBIT TTM = 4.41m USD
EBITDA TTM = 48.9m USD
Long Term Debt = 658.4m USD (from longTermDebt, last quarter)
Short Term Debt = 22.6m USD (from shortTermDebt, last quarter)
Debt = 681.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 459.5m USD (from netDebt column, last quarter)
Enterprise Value = 1.68b USD (1.22b + Debt 681.0m - CCE 221.5m)
Interest Coverage Ratio = 0.14 (Ebit TTM 4.41m / Interest Expense TTM 30.9m)
FCF Yield = 5.24% (FCF TTM 88.3m / Enterprise Value 1.68b)
FCF Margin = 6.62% (FCF TTM 88.3m / Revenue TTM 1.33b)
Net Margin = -2.50% (Net Income TTM -33.4m / Revenue TTM 1.33b)
Gross Margin = 26.29% ((Revenue TTM 1.33b - Cost of Revenue TTM 982.7m) / Revenue TTM)
Gross Margin QoQ = 25.09% (prev 26.81%)
Tobins Q-Ratio = 1.04 (Enterprise Value 1.68b / Total Assets 1.61b)
Interest Expense / Debt = 0.74% (Interest Expense 5.05m / Debt 681.0m)
Taxrate = 22.88% (9.94m / 43.4m)
NOPAT = 3.40m (EBIT 4.41m * (1 - 22.88%))
Current Ratio = 1.89 (Total Current Assets 866.5m / Total Current Liabilities 458.5m)
Debt / Equity = 1.68 (Debt 681.0m / totalStockholderEquity, last quarter 404.6m)
Debt / EBITDA = 9.40 (Net Debt 459.5m / EBITDA 48.9m)
Debt / FCF = 5.21 (Net Debt 459.5m / FCF TTM 88.3m)
Total Stockholder Equity = 345.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.07% (Net Income -33.4m / Total Assets 1.61b)
RoE = -9.66% (Net Income TTM -33.4m / Total Stockholder Equity 345.6m)
RoCE = 0.44% (EBIT 4.41m / Capital Employed (Equity 345.6m + L.T.Debt 658.4m))
RoIC = 0.57% (NOPAT 3.40m / Invested Capital 599.4m)
WACC = 6.89% (E(1.22b)/V(1.90b) * Re(10.41%) + D(681.0m)/V(1.90b) * Rd(0.74%) * (1-Tc(0.23)))
Discount Rate = 10.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.65%
[DCF Debug] Terminal Value 60.59% ; FCFE base≈124.7m ; Y1≈81.9m ; Y5≈37.4m
Fair Price DCF = 3.43 (DCF Value 523.6m / Shares Outstanding 152.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 37.47 | EPS CAGR: 126.8% | SUE: 1.81 | # QB: 1
Revenue Correlation: -15.78 | Revenue CAGR: 16.79% | SUE: 2.80 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.19 | Chg30d=-0.020 | Revisions Net=-3 | Analysts=14
EPS next Year (2026-12-31): EPS=0.89 | Chg30d=-0.029 | Revisions Net=-2 | Growth EPS=+32.1% | Growth Revenue=+14.1%
Additional Sources for ARRY Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle